The Academy of Managed Care Pharmacy (AMCP) is pleased to provide comments to the Food and Drug Administration (FDA) on the Draft Guidance for Industry on Generic Drug User Fee Act (GDUFA) Amendments of 2012: Questions and Answers. This letter is in response to the Federal Register notice issued on August 27, 2012 requesting stakeholder input on the questions and answers that provide insight into the implementation of GDUFA.
**** Additional comments attached*****
Attachments:
Academy of Managed Care Pharmacy AMCP Comments
Title: Academy of Managed Care Pharmacy AMCP Comments
Academy of Managed Care Pharmacy (AMCP) - Comment
This is comment on Notice
Draft Guidances for Industry: Generic Drug User Fee Amendments of 2012, Questions and Answers
View Comment
Attachments:
Academy of Managed Care Pharmacy AMCP Comments
Title:
Academy of Managed Care Pharmacy AMCP Comments
Related Comments
Public Submission Posted: 10/02/2012 ID: FDA-2012-D-0880-0003
Oct 26,2012 11:59 PM ET
Public Submission Posted: 10/02/2012 ID: FDA-2012-D-0880-0004
Oct 26,2012 11:59 PM ET